trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Ye J et al. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. 2007 J. Virol. pmid:17596302
Tuncel M et al. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. 2007 Cancer Biother. Radiopharm. pmid:17600477
Kaneko M et al. Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors. 2007 Int. Arch. Allergy Immunol. pmid:17541273
Schwechter BR et al. Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. 2007 Invest. Ophthalmol. Vis. Sci. pmid:17525221
Turaga RV et al. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration. 2007 Aging Cell pmid:17521388
Wu J et al. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. 2007 BMC Genomics pmid:17524140
Wang LG et al. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. 2007 Mol. Carcinog. pmid:16921492
Choy SW et al. C. elegans SIN-3 and its associated HDAC corepressor complex act as mediators of male sensory ray development. 2007 Biochem. Biophys. Res. Commun. pmid:17506990
Royo H et al. Bsr, a nuclear-retained RNA with monoallelic expression. 2007 Mol. Biol. Cell pmid:17507654
Lin T et al. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. 2007 Surgery pmid:17560255
Bai L and Merchant JL ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate. 2007 Biochem. Biophys. Res. Commun. pmid:17560543
Rigamonti D et al. Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators. 2007 J. Biol. Chem. pmid:17565993
Uchida H et al. Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. 2007 Endocrinology pmid:17068141
Roy S and Tenniswood M Site-specific acetylation of p53 directs selective transcription complex assembly. 2007 J. Biol. Chem. pmid:17121856
Huang JC et al. Changes in histone acetylation during postovulatory aging of mouse oocyte. 2007 Biol. Reprod. pmid:17582009
Lee S et al. Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17588744
Henkens T et al. Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. 2007 Toxicol. Appl. Pharmacol. pmid:17125810
Fang S et al. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism. 2007 Mol. Cell. Biol. pmid:17145766
Vikhanskaya F et al. Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53. 2007 Nucleic Acids Res. pmid:17344317
Krennhrubec K et al. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17346959
Vincent A et al. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. 2007 Oncogene pmid:17471237
Zhang C et al. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. 2007 J. Pathol. pmid:17471463
Gensert JM et al. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells. 2007 Neurobiol. Dis. pmid:17481908
Mayo C et al. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression. 2007 J. Cell. Physiol. pmid:17311291
Jung EJ et al. Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. 2007 Cancer Lett. pmid:16647201
Avila AM et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. 2007 J. Clin. Invest. pmid:17318264
Snykers S et al. Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. 2007 BMC Dev. Biol. pmid:17407549
Horion J et al. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha. 2007 J. Biol. Chem. pmid:17409387
Ryningen A et al. Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting. 2007 Leuk. Res. pmid:17416413
Loudni L et al. Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17624773
Kato N et al. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. 2007 Leukemia pmid:17625602
Bu Y and Gelman IH v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex. 2007 J. Biol. Chem. pmid:17626016
Dombrowsky H and Uhlig S Steroids and histone deacetylase in ventilation-induced gene transcription. 2007 Eur. Respir. J. pmid:17626110
Subramanian C et al. CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. 2007 Neoplasia pmid:17603632
Chen B and Cepko CL Requirement of histone deacetylase activity for the expression of critical photoreceptor genes. 2007 BMC Dev. Biol. pmid:17603891
Glenisson W et al. Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation. 2007 Biochim. Biophys. Acta pmid:17610967
Zhang X et al. Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression. 2007 Biochem. Cell Biol. pmid:17612628
Shi J et al. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. 2007 Cancer Res. pmid:17616702
Perales M and Más P A functional link between rhythmic changes in chromatin structure and the Arabidopsis biological clock. 2007 Plant Cell pmid:17616736
Zhao Y et al. Roles of histone acetylation modification in basal and inducible expression of hsp26 gene in D. melanogaster. 2007 Mol. Cell. Biochem. pmid:17619947
El-Khoury V et al. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. 2007 Br. J. Cancer pmid:17667922
Khaw AK et al. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. 2007 Mutat. Res. pmid:17669439
Rouhi A et al. Plasticity of Ly49g expression is due to epigenetics. 2007 Mol. Immunol. pmid:16750269
Gahr S et al. The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. 2007 Int. J. Oncol. pmid:17671683
Tomita A et al. Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy. 2007 Int. J. Hematol. pmid:17675267
Wang J et al. Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes. 2007 J. Biol. Chem. pmid:17675290
Di Renzo F et al. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity. 2007 Toxicol. Appl. Pharmacol. pmid:17320131
Sekhavat A et al. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. 2007 Biochem. Cell Biol. pmid:18059533
Seo H et al. Modulation of immunoglobulin gene conversion in chicken DT40 by enhancing histone acetylation, and its application to antibody engineering. 2007 Biotechnol. Genet. Eng. Rev. pmid:18059633
Mazières J et al. Epigenetic regulation of RhoB loss of expression in lung cancer. 2007 BMC Cancer pmid:18047684
Shimazu T et al. [Biological diversity of protein lysine acetylation which has been revealed by small molecule inhibitors]. 2007 Tanpakushitsu Kakusan Koso pmid:18051411
Platta CS et al. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. 2007 J. Surg. Res. pmid:17612559
Yoshida M [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. 2007 Tanpakushitsu Kakusan Koso pmid:18051427
Mogal AP et al. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation. 2007 J. Biol. Chem. pmid:17602165
Huber LC et al. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. 2007 Arthritis Rheum. pmid:17665426
Ishihara K et al. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors. 2007 Life Sci. pmid:17258775
Meng CF et al. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. 2007 World J. Gastroenterol. pmid:18069755
Putignano E et al. Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity. 2007 Neuron pmid:17329213
Vibhakar R et al. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma. 2007 Neuro-oncology pmid:17329407
Pan L et al. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. 2007 Cancer pmid:17330857
Rao J et al. Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells. 2007 Biochem. Biophys. Res. Commun. pmid:17869223
Karagiannis TC et al. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. 2007 Oncogene pmid:17213813
Ohoka N et al. Critical and functional regulation of CHOP (C/EBP homologous protein) through the N-terminal portion. 2007 J. Biol. Chem. pmid:17872950
Elaut G et al. A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures. 2007 J. Pharmacol. Exp. Ther. pmid:17218485
Kenneth NS et al. TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:17848523
Ferreira R et al. Site-specific acetylation of ISWI by GCN5. 2007 BMC Mol. Biol. pmid:17760996
Jamaluddin MD et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. 2007 Blood pmid:17698632
Ting CH et al. Stat5 constitutive activation rescues defects in spinal muscular atrophy. 2007 Hum. Mol. Genet. pmid:17220171
Hong S et al. Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A. 2007 Anticancer Drugs pmid:17704650
McCool KW et al. The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation. 2007 J. Biol. Chem. pmid:17204470
Robertson DM et al. Insulin-like Growth Factor Binding Protein-3 expression in the human corneal epithelium. 2007 Exp. Eye Res. pmid:17709104
Bártová E et al. Differentiation-specific association of HP1alpha and HP1beta with chromocentres is correlated with clustering of TIF1beta at these sites. 2007 Histochem. Cell Biol. pmid:17205308
Chen WY et al. Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1). 2007 Mol. Cell. Biol. pmid:17709382
Kuang PP et al. Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17209135
Bazhin AV et al. Expression of GAGE family proteins in malignant melanoma. 2007 Cancer Lett. pmid:17194529
Markova NG et al. Inhibition of histone deacetylation promotes abnormal epidermal differentiation and specifically suppresses the expression of the late differentiation marker profilaggrin. 2007 J. Invest. Dermatol. pmid:17195011
Fujita Y et al. Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1. 2007 Dev. Cell pmid:17199038
Kovács P et al. Effect of histone deacetylase inhibitor trichostatin A (TSA) on the microtubular system of Tetrahymena. 2007 Acta. Biol. Hung. pmid:18277464
Lattal KM et al. Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. 2007 Behav. Neurosci. pmid:17907845
Yang H et al. Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent. 2007 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:16973938
Zhang Y et al. An epigenetic modifier results in improved in vitro blastocyst production after somatic cell nuclear transfer. 2007 Cloning Stem Cells pmid:17907946
Noro R et al. PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors. 2007 Int. J. Oncol. pmid:17912443
Zhao TC et al. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. 2007 Cardiovasc. Res. pmid:17884027
Wu P et al. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A]. 2007 Zhonghua Zhong Liu Za Zhi pmid:17892126
Akao Y et al. Downregulation of microRNAs-143 and -145 in B-cell malignancies. 2007 Cancer Sci. pmid:17892514
Murga M et al. Global chromatin compaction limits the strength of the DNA damage response. 2007 J. Cell Biol. pmid:17893239
Schnur N et al. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. 2007 Biochim. Biophys. Acta pmid:17894944
Liu T et al. Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. 2007 Carcinogenesis pmid:16990345
Kim EJ et al. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. 2007 Mol. Cell pmid:17964266
Shen L et al. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. 2007 PLoS Genet. pmid:17967063
Stiehl DP et al. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. 2007 Cancer Res. pmid:17332356
Jung J and Bonini N CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. 2007 Science pmid:17332375
Jaffe RC et al. Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression. 2007 J. Mol. Endocrinol. pmid:17339403
Alimirah F et al. IFI16 in human prostate cancer. 2007 Mol. Cancer Res. pmid:17339605
Wu Y and Guo SW Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. 2007 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:17296257
Cao D et al. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. 2007 Am. J. Respir. Cell Mol. Biol. pmid:17395887
Li Y et al. Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-kappaB acetylation in human neuroblastoma cells. 2007 J. Neurochem. pmid:17250678
Suzuki T et al. Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor. 2007 Bioorg. Med. Chem. Lett. pmid:17257837
Scott SA et al. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. 2007 Exp. Hematol. pmid:17258075
Hummel M et al. Transcriptional reactivation of murine cytomegalovirus ie gene expression by 5-aza-2'-deoxycytidine and trichostatin A in latently infected cells despite lack of methylation of the major immediate-early promoter. 2007 J. Gen. Virol. pmid:17374752